Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders

Organophosphate compounds (OPs) interfere with neurodevelopment and are neurotoxic for humans and animals. They are first biotransformed to the more toxic oxon form, and then hydrolyzed to specific metabolites by the enzyme paraoxonase/arylesterase, encoded by the gene <i>PON1</i> locate...

Full description

Bibliographic Details
Main Authors: Ignazio Stefano Piras, Stefano Gabriele, Laura Altieri, Federica Lombardi, Roberto Sacco, Carla Lintas, Barbara Manzi, Paolo Curatolo, Maria Nobile, Catia Rigoletto, Massimo Molteni, Antonio M. Persico
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Antioxidants
Subjects:
arylesterase
attention deficit/hyperactivity disorder (ADHD)
autism
autism spectrum disorder
developmental language disorder
organophosphate
Online Access:https://www.mdpi.com/2076-3921/10/2/164

Internet

https://www.mdpi.com/2076-3921/10/2/164

Similar Items